Archives for May 14, 2007

← 2007

Contract manufacturing news in brief

By  Katrina Megget

Robinson Pharma, Vybion, Prosensa, Diosynth Biotechnology, ImmunoGen and Novogen have all recently announced new contract manufacturing deals.

Australian spin-offs pursuing nanotechnology innovations

By  Pete Mansell

A transdermal patch for needle-free delivery of insulin and a diagnostic test for rapid detection of meningococcal disease are among the products under development by two new Australian companies set up to commercialise the research outcomes of...

FDA approves new inhalable COPD treatment

By  Anna Lewcock

The market's first nebulized form of formoterol fumarate for chronic obstructive pulmonary disease (COPD) has been given the go ahead by the US Food and Drug Administration (FDA).

Production hitch stems US supply of ProQuad combination vaccine

By  Pete Mansell

Lower than expected yields of varicella zoster virus (VZV) have forced Merck & Co to run down US supplies of ProQuad, its all-in-one children's vaccine for measles, mumps, rubella (German measles) and varicella (chickenpox).